Dianthus Therapeutics Inc. (87E)
XSTU
84.50
-3.50 (-3.98%)
Real-time Data
06:00 AM
Day's Range
84.0088.50
52 wk Range
28.40101.00
Financial Statements - 87E - Dianthus Therapeutics Inc.
Revenue
2.03M▼ 67.3%
Net Income
-162.33M▼ 91.1%Net Margin -7973.3%
EBITDA
-177.95M▼ 75.3%
Free Cash Flow
-129.27M▼ 65.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 2.03M | 6.23M | 2.82M | 6.41M | 1.47M |
| Cost of Goods | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
 Operating Expense | - | - | - | - | - |
| Operating Income | -177.93M | -101.86M | -48.17M | -29.70M | -13.08M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | -523K | -470K | -145K | 84K | -26K |
| Pre Tax Income | -162.33M | -84.96M | -43.55M | -28.47M | -13.10M |
| Income Tax | - | - | - | - | - |
| Net Income | -162.33M | -84.96M | -43.55M | -28.47M | -13.10M |
| EPS Basic | -4.2 | -2.55 | -8.45 | -1.921756 | -0.884685 |
| EPS Diluted | -4.2 | -2.55 | -8.45 | -1.921756 | -0.884685 |
| Basic Shares Outstanding | 38.61M | 33.31M | 5.61M | 15.49M | 15.49M |
| Diluted Shares Outstanding | 38.61M | 33.31M | 5.61M | 15.49M | 15.49M |
| Ebit | -177.93M | -101.86M | -48.17M | -29.70M | -13.08M |
| Ebitda | -177.95M | -101.53M | -47.73M | -29.69M | -13.06M |
| Net Income Continuous Operations | -162.33M | -84.96M | -43.55M | -28.47M | -13.10M |
| Minority Interests | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
